当前位置: 首页 > 期刊 > 《中国保健营养.中旬刊》 > 20144
编号:13690671
抑癌基因与肝细胞癌变(2)
http://www.100md.com 2014年4月1日 《中国保健营养·中旬刊》 20144
     [9] Colak D, Chisti M, Al-Bakheet A, et al. Integrative and comparative genomic analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old [J]. Mol Cancer. 2010,9:146.doi: 10.1186/1476-4598-9-146.

    [10] Teoh NC. Proliferative drive and liver carcinogenesis: Too much of good things? [J] J Gastroenterol Hepatol. 2009,24(12):1817-25.

    [11] Tannapfel A, John K, Mise N, et al. Autonomous growth and hepatocarcino- genesis in transgenic mice expressing the p53 family inhibitor DNp73 [J]. Carcinogenesis. 2008,29 (1):211-8.

    [12] Douglas H, Robert A W. Hallmarks of Cancer: The Next Generation [J]. Cell. 2011,4 (144):646-74.

    [13] Van den Heuvel S, Dyson N J. Conserved functions of the pRB and E2F families [J]. Nat Rev Mol Cell Biol. 2008,9(9):713–24.

    [14] Azechi H, Nishida N, Fukuda Y, et al. Disruption of the p16/cyclin D1/ retinoblastoma protein pathway in the majority of human hepatocellular carcinomas [J]. Oncology. 2001, 60(4):346–54.

    [15] Mayhew C N, Carter S L, Fox S R, et al. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis [J]. Gastroenterology. 2007,133(3):976-84.15, http://www.100md.com(刘晓康 李清)
上一页1 2